- Fentanyl and the ‘fourth wave’ of the opioid epidemicBy natalie@addiction-ssa.orgPublished On: 30 November 2023Categories: PodcastComments Off on Fentanyl and the ‘fourth wave’ of the opioid epidemic
- The public health impact of legalising cannabisBy natalie@addiction-ssa.orgPublished On: 6 October 2023Categories: PodcastComments Off on The public health impact of legalising cannabis
- What do power and privilege have to do with bacterial infections?By natalie@addiction-ssa.orgPublished On: 13 September 2023Categories: PodcastComments Off on What do power and privilege have to do with bacterial infections?
- The first 72 hours of long-acting buprenorphineBy natalie@addiction-ssa.orgPublished On: 9 June 2023Categories: PodcastComments Off on The first 72 hours of long-acting buprenorphine
- A medication-based intervention for people who use benzodiazepinesBy natalie@addiction-ssa.orgPublished On: 5 May 2023Categories: PodcastComments Off on A medication-based intervention for people who use benzodiazepines
- ‘We smoke, but we’re not smokers’By natalie@addiction-ssa.orgPublished On: 21 April 2023Categories: PodcastComments Off on ‘We smoke, but we’re not smokers’
- Overdose deaths, COVID-19, and Hurricane KatrinaBy natalie@addiction-ssa.orgPublished On: 10 March 2023Categories: PodcastComments Off on Overdose deaths, COVID-19, and Hurricane Katrina
- Relapse: what is it and what does it mean to people who experience it?By natalie@addiction-ssa.orgPublished On: 19 January 2023Categories: PodcastComments Off on Relapse: what is it and what does it mean to people who experience it?
- The rise of disposable vaping productsBy natalie@addiction-ssa.orgPublished On: 4 January 2023Categories: PodcastComments Off on The rise of disposable vaping products
- Developing autism-friendly services: ‘calm environments and a range of treatment options benefit everybody’By natalie@addiction-ssa.orgPublished On: 16 December 2022Categories: PodcastComments Off on Developing autism-friendly services: ‘calm environments and a range of treatment options benefit everybody’